BGI Buys 37 of Life Tech's Ion Proton Sequencers | GenomeWeb

NEW YORK (GenomeWeb News) – China's BGI said it has purchased 37 of Life Technologies' Ion Proton next-generation sequencing systems and will add at least 12 more machines by the end of the year.

Additionally, Shenzhen, China-based BGI said it has signed a supply and licensing agreement with Life Tech.

BGI will use the Proton for exome and transcriptome sequencing, as well as aneuploidy testing, according to a statement. The institution has already validated the Proton's PI chip, delivering 80 million reads in two- to three-hour sequencing runs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.